logo
welcome
Reuters

Reuters

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Reuters
Summary
Nutrition label

79% Informative

Cigna will remove AbbVie ’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025 .

Pharmacy benefit managers have come under increased scrutiny from U.S. agencies and lawmakers this year for their alleged role in keeping drug prices high.

VR Score

89

Informative language

96

Neutral language

48

Article tone

formal

Language

English

Language complexity

61

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links